Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

Dealmaking still a key to growth: Q3’23 M&A trends in life sciences

Even with continued uncertainty in the US economy, the data suggests that life sciences M&As could pick up in 2024.

M&A activity in the life sciences sector held steady for the fifth consecutive quarter despite concerns over inflation, recession, and high interest rates. And with recession fears easing, interest rates appearing to be topping out, and inflation remaining largely under control, the expectation is that M&A activity in the life sciences industry will pick up in 2024.

However, dealmaking trends and considerations vary in each of its three major subsectors:

  • Medical devices: While deal volume reached its lowest level since Q1’20, several factors are expected to drive a rebound in 2024. This includes advances in AI-supported devices in surgery, diabetic care, cardiology, and other areas.
  • Pharmaceutical services: Q3’23 dealmaking in this subsector tied for the lowest quarterly volume since Q3’20 as many companies in this space are still recovering from the pandemic. But demand for many pharma services continues to be strong and private equity seems increasingly ready to get back into this space.
  • Diagnostic and lab services: Diagnostics and lab services dealmaking reached its highest volume in more than a year. Technological advances and changes in consumer attitudes regarding diagnostic testing outside of hospitals and doctors’ offices (e.g., COVID home tests) have contributed to this increase. This space presents potential opportunities for investors, including private equity and corporate acquirers.

Download our report to learn more about M&A activity in the life science sector, the factors that may impact this activity, potential pitfalls to avoid, and how to position yourself to take advantage of investment opportunities as they arise.

Dive into our thinking:

Dealmaking still a key to growth

M&A trends in life sciences

Download PDF

Explore services tailored to your business

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.